tyramine has been researched along with Malignant Carcinoid Syndrome in 2 studies
Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Studnitz, W | 1 |
| Waldenström, J | 1 |
| Kazi, MU | 1 |
| Grover, V | 1 |
2 other studies available for tyramine and Malignant Carcinoid Syndrome
| Article | Year |
|---|---|
[Pharmacological and therapeutic studies (p-chlorphenylalanin) on carcinoid syndrome in 11 cases].
Topics: 5-Hydroxytryptophan; Aged; Blood Pressure; Bradykinin; Epinephrine; Female; Fenclonine; Humans; Hydr | 1971 |
Carcinoid tumors and the carcinoid syndrome.
Topics: Adult; Aged; Bradykinin; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Kinins; Lung N | 1969 |